The autonomic system and sympathetic activation appears integral in the pathogenesis of acute mountain sickness (AMS) at high altitude (HA), yet a link between heart rate variability (HRV) and AMS has not been convincingly shown. In this study we investigated the utility of the smartphone-derived HRV score to predict and diagnose AMS at HA. Methods: Twenty-one healthy adults were investigated at baseline at 1400 m and over 10 days during a trek to 5140 m. HRV was recorded using the ithlete HRV device. Results: Acute mountain sickness occurred in 11 subjects (52.4%) at .2650 m. HRV inversely correlated with AMS Scores (r 5 20.26; 95% CI, 20.38 to 20.13: P , 0.001). HRV significantly fell at 3700, 4100, and 5140 m versus low altitude. HRV scores were lower in those with both mild (69.7 6 14.0) and severe AMS (67.1 6 13.1) versus those without AMS (77.5 6 13.1; effect size n 2 5 0.043: P 5 0.007). The HRV score was weakly predictive of severe AMS (AUC 0.74; 95% CI, 0.58-0.89: P 5 0.006). The change (delta) in the HRV Score (compared with baseline at 1400 m) was a moderate diagnostic marker of severe AMS (AUC 0.80; 95% CI, 0.70-0.90; P 5 0.0004). A fall in the HRV score of .5 had a sensitivity of 83% and specificity of 60% to identify severe AMS (likelihood ratio 1.9). Baseline HRV at 1400 m was not predictive of either AMS at higher altitudes. Conclusions: The ithlete HRV score can be used to help in the identification of severe AMS; however, a baseline score is not predictive of future AMS development at HA.
INTRODUCTION
High altitude (HA) illness consists of acute mountain sickness (AMS), which is usually a self-limiting collection of symptoms including headache and lethargy, which can lead to? HA cerebral edema (HACE) and HA pulmonary edema (HAPE). High altitude cerebral edema and HAPE are life-threatening. 1 The incidence of AMS is dependent on a number of factors that include individual susceptibility, the speed of ascent, and altitude attained. 2 It is known to affect .50% of persons at ascending to an altitude of 5000 m. [1] [2] [3] [4] The mechanism of AMS development is highly complex and is still not fully understood. 1 High-altitude-related hypoxia and changing homeostasis triggers a number of well-established physiological responses, which include the adrenal medullary release of epinephrine and an increase in whole body and tissue specific sympathetic nerve activity. 5 This leads to an increase in metabolic, heart, and respiratory rate and changes in cerebral blood flow, which act to counteract the effects of hypobaric hypoxia. [5] [6] [7] There is accumulating evidence to suggest that the autonomic system and alterations in the sympathetic/ parasympathetic balance may play an important pathogenic role in the development of AMS and its susceptibility. [7] [8] [9] [10] [11] Heart rate variability (HRV) represents an increasingly used, yet noninvasive method of assessing autonomic function. Heart rate variability is quantified by measuring changes in cardiac beat-to-beat (R-R) intervals, which are under continuous autonomic control. 12 Conditions that are known to affect the sympathetic/parasympathetic balance such as intercurrent illness, cardiovascular disease, physical overtraining, and mental stress have been shown to lead to a reduction in HRV. [13] [14] [15] Changes in HRV have been demonstrated on ascent to HA and typified by an increase in measures of sympathetic and a decrease in parasympathetic activity. 16, 17 However, a link between alterations in HRV and AMS development at HA has not been convincingly shown. 3, [18] [19] [20] [21] Traditional methods of HRV measurement have required relatively large and expensive equipment with a need for at least 5 minutes of electrocardiographic (ECG) recording. 22 The ithlete (HRV Fit Ltd, Southampton, United Kingdom) system is a recently available method of noninvasive HRV assessment from only 55 seconds of recording obtained via a chest strap or finger sensor linked to a mobile smartphone. The ithlete generates an intuitive 1 to 100 HRV score, which is a logarithmic adaptation of the root mean square of successive R-R intervals (RMSSD) provided by traditional HRV devices. 23 It has been shown that the RMSDD can be derived from shorter recording times and is less prone to the effects of respiration, which is advantageous for the HA environment where hypoxia and hyperventilation is typical. [24] [25] [26] The ithlete HRV score has been shown to provide good to excellent agreement with the RMSSD obtained from a standard 5-minute electrocardiographic recording at sea level and more recently at HA. 25, 27 The aim of this study was to investigate, for the first time, the practical use of the ithlete HRV monitor as a way of monitoring acclimatization to HA and the onset of AMS.
METHODS

Subjects
Healthy British Military service personnel aged .18 years were included. Health status was confirmed after a detailed baseline health questionnaire. All subjects had to be in date with their fitness assessments including the military fitness standard for a 1.5-mile run. Key exclusion criteria included subjects with any history of cardiac arrhythmias or need for either rate or rhythm controlling medications. All subjects lived at low altitude and none had prior exposure to .1400 m terrestrial altitude in the 4 weeks before this study.
Data collection took place during a trek to Dhaulagiri base camp (western Nepal). Subjects were all part of the British Services Dhaulagiri Medical Research Expedition. After arriving at Kathmandu at 1400 m, the subjects travelled by road to 890 m and then 2650 m before commencing the ascent on foot to 5140 m (over Dhamphus Pass, 5240 m) over 10 days (Figure 1 ).
Recording of Heart Rate Variability (HRV)
Heart rate variability was recorded at approximately 0700 each morning using a finger sensor and linked smartphone via the ithlete app (HRV Fit Ltd) as previously described and validated. 25, 27 All participants were studied postmicturition but before breakfast or caffeine. All subjects were seated, wearing warm clothing in either a tent or building. All subjects were encouraged to rest for at least 5 minutes before the HRV recordings were obtained. The ithelte acquires a 55-second recording with visual breathing prompts to regulate the rate of both inspiration and expiration to standardize the HRV measurements. The ithlete modifies the acquired RMSSD by taking the natural log transformation and multiplying by 20 (lnRMSSD 3 20) to provide a more interpretable HRV score for the user on a ;100-point scale. 23 It has a patented algorithm for the exclusion of both artifacts and ectopic beats whereby R-R (P-P) intervals of ,500 milliseconds or .2000 milliseconds are excluded as are abnormal adjacent R-R intervals whose difference significantly exceeds the mean R-R interval.
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Acute Mountain Sickness Scores Measurement of AMS was undertaken at the same time that HRV assessments were performed using the Lake Louis Scoring System (LLS). 29, 30 A total score of .3 in the presence of headache was used to diagnose AMS and a score .5 was considered consistent with severe AMS.
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Physiological Measurements
Oxygen saturations (SpO 2 ) and heart rate were measured using a Nonin Onyx (Nonin Medical Inc, Plymouth, Minnesota) pulse oximeter just before the assessment of HRV.
Ethics
The study was approved by the Ministry of Defence Research Ethics Committee and complied with the standards set in the Declaration of Helsinki. All subjects gave written informed consent.
Statistical Analysis
Statistical calculations and figures were performed using GraphPad Instat and GraphPad Prism version 4.00 for Windows. Normality of continuous data was assessed after inspection and the Kolmogorov-Smirnov statistic. All continuous data are presented as the mean 6 standard deviation. Independent 2 group comparisons of continuous data were analyzed using an unpaired t test or MannWhitney test for parametric and nonparametric data respectively. Comparisons of continuous data from $3 groups of parametric and on parametric data were performed using a one-way ANOVA or Kruskal-Wallis test respectively. The effect size (n) for any potential changes in HRV with HA was also calculated as the sum of squares for between-treatment effects divided by the total sum of squares. Correlation analyses were performed using Pearson correlation and Spearman's rank correlation with 95% confidence intervals depending on data normality. Receiver operating characteristic (ROC) curves were constructed to assess the sensitivity and specificity of the ithlete and the area under the curve (AUC) for the HRV score to accurately identify subjects with AMS was determined. A P value of ,0.05 was considered significant for all comparisons.
RESULTS
Twenty-one subjects (20 men, 1 woman) aged 36.2 6 6.9 (years were studied over their first 13 days in Nepal (Table 1) . Seventeen subjects reached 5140 m on day 11, 2 on day 13, www.cjsportmed.com and 2 beyond the study period. There was a significant fall in SpO 2 and increase in resting heart rate with gains in HA ( Table 2 ). There was also an overall increase in LLS at HA ( There was a nonsignificant trend to reducing HRV score with increasing HA (n 2 5 0.042; P 5 0.09) ( Table 2 and Figure 2 ). However, this fall was significant at 3700, 4100 and 5140 m versus 890 m. The HRV score fell with increasing AMS Scores (ANOVA n 2 5 0.043; P 5 0.007) (Figure 3 ), but this difference was only significant on posttest between those with a LLS of 0 versus those with a LLS .5. Heart rate variability scores were significantly lower in those with AMS (mild and severe combined) 67.9 6 13.1 versus those without AMS 77.5 6 13.1 (P 5 0.002). Heart rate variability scores significantly fell from 77.5 6 13.1 for those with no AMS to 69.7 6 14.0 with mild AMS and 67.1 6 13.1 with severe AMS (P 5 0.007, Figure 4) ; however, the difference was only significant between those without AMS and those with severe (not mild) AMS on posttest.
The HRV score was very marginally better at distinguishing severe AMS versus those without severe AMS (ROC curve 0.74; 95% CI, 0.58-0.89: P 5 0.006) than differentiating all AMS (mild and severe combined) from no AMS [area under the curve (AUC) 0.71: 95% CI, 0.58-0.84; P 5 0.002] ( Figure 5 ). An HRV score of ,76 had a sensitivity of 83% and a specificity of 53% for the correct identification of severe AMS at a likelihood ration of 1.80 ( Figure 5 ). However, the change (delta) in the ithlete HRV score (compared with baseline at 1400 m) was a better predictor of severe AMS (AUC 0.80; 95% CI, 0.70-0.90; P 5 0.0004) (Figure 6) . A fall in the HRV score of .6 points compared had a sensitivity of 83% and specificity of 60% to identify severe AMS (likelihood ration 1.9) (Figure 6 ). There was no difference in the HRV scores at 1400 m between those who did or did not develop severe or any AMS at higher altitudes.
DISCUSSION
This is the first study, to the author's knowledge, to investigate the link between AMS and HRV at HA to 5140 m using a portable smartphone HRV device (ithlete). The ithlete HRV score inversely correlated with the LLS but was a relatively weak discriminator for the identification of AMS and its severity. However, a fall in the HRV score, at HA versus baseline, of .6 versus baseline was a moderate albeit nonspecific marker of severe AMS.
There is an increasing body of research that has shown that HA exposure leads to a reduction in HRV. This is thought to relate to a significant increase in sympathetic and a decrease in parasympathetic tone. 17, 18, 22 With acclimatization, there appears to be progressive shift toward a higher parasympathetic tone. 31, 32 Much less is known about the link between HRV and AMS. There are data to suggest that changes in HRV are linked to the AMS susceptibility and development. 19, 22 But there is also data to the contrary challenging the potential link. 20, 21 This conflicting data may be partly explained by the marked differences in the design, ascent profile, and the methods of HRV recording across the studies. Karinen et al studied 36 climbers on 4 different expeditions and 3 differing ascents. The authors found that those with a lower HRV [RMSSD 2min and HF (high frequency) 2min from a 5-minute HRV recording] at 2400 m predicted those who later developed AMS at moderate altitudes (3000-4300 m). 22 Huang et al study 32 patients over a progressive HA trek to 3440 m. They noted that those with both (high frequency) HF % , 20% (suggesting reduced parasympathetic tone) and low-frequency/high-frequency (LF/HF) ratio .1.3 (increased sympathetic balance) measured at 1317 m had an odds ratios of 7.00 (P 5 0.047) for the subsequent development of develop AMS at 3440 m (Huang 2013). 19 The authors did not report data on the RMSSD. In our study while we did observe significantly lower ithlete HRV (RMSSD) scores in those with AMS and more severe AMS, lower altitude HRV scores failed to predict AMS development at HA. Furthermore, the effect size for change in HRV with worsening AMS severity was modest.
One of the major additional confounders in all of these studies examining the relationship of HRV to symptom of AMS has been in the definition of AMS itself. The diagnosis of AMS is made using a self-reported questionnaire-based assessment, most notably the LLS and is highly subjective and therefore likely to be influenced by a subject's expectations or aspirations and it can be a relatively poor predictor of illness. 33, 34 For example, in a previous study of 248 healthy adults travelling to 3200 m, Bartsch has noted that only 61% of the mountaineers reporting a LLS .5 actually said they felt ill. 35 Hence, a more reproducible and objective measure of HA-related illness would be welcome. The rational for using HRV to improve the detection of AMS is strong. While the underlying pathophysiology of AMS is still poorly understood, current evidence suggests that it involves vasogenic cerebral edema secondary to hypoxia-induced sympathetic activation. 1 The normal physiological diuresis at HA, which acts to reduce plasma volume and increase in hematocrit (to improve tissue oxygenation), is also affected leading to a reduced water clearance and a positive net water balance. 36 Changes in plasma volume which are integral to the HA acclimatization and AMS development are strongly influenced by alterations in parasympathetic tone. 37 Heart rate variability is also heavily affected by a number of other autonomic stressors such as fitness levels, physical fatigue, cold and exertion, which are important factors at HA and are known to be contributory factors to AMS development and progression. 38 One of the greatest clinical applications of the ithlete and other HRV measures is in the detection of overtraining, which shares many features in common with AMS. Hence, further studies examining the utility of HRV to monitor recovery from exercise at HA and to tailor individuals' acclimatization, rather than relying on guidelines such as 300 m ascent per day, would be welcome. The ithlete is currently marketed with a visual display of other domains such as sleep, fatigue, irritability and muscle soreness, which could be potentially adapted to give a scale related to the LLS and is an area worthy of further research.
This study has a number of limitations and strengths that need to be acknowledged. The ambient temperature varied throughout the study and the HRV measurements were performed in tents above 1400 m. It is well known that change in both environment and temperature can influence HRV, and due to the nature of this study, it was not possible to adjust for these factors. 38 In this study, we used a finger probe rather than a Bluetooth chest strap sensor to acquire heart beat data and successful data recording was not possible in 7% which could have influenced the findings. The ithlete only provides a single measure of HRV from a very short recording time. Hence, we do not know whether our findings would be different if another HRV platform and a 5-minute recording period with a wider array of HRV data outputs include frequency domain analyses were used. The ithlete HRV score is related to the RMSSD and is considered a marker of relative parasympathetic activity and does not assess sympathetic tone or the sympathetic/parasympathetic balance provided by more sophisticated devices. However, the aim of this study was to assess the utility of a simple, inexpensive, portable, and user-friendly device that is widely available to potentially predict HA-related illness and hence maximizing the clinical impact of a potentially strongly positive finding. The key strengths of this study was that all subjects underwent the same exercise, diet, and acclimatization protocol and the altitude achieved was significant and greater than the majority of published HRV studies at HA.
In summary, this is the first paper to show a practical application of a simple measure of HRV to provide an objective measure of severe AMS. A fall in the ithlete HRV score of .6 points from baseline had moderate precision for the detection of severe AMS. . Receiver operating characteristic curve for change in heart rate variability score and identification of severe acute mountain sickness.
